Provided by Tiger Trade Technology Pte. Ltd.

Mereo Biopharma Group Plc

0.4020
+0.02887.72%
Pre-market: 0.4000-0.0020-0.50%04:22 EDT
Volume:3.05M
Turnover:1.23M
Market Cap:63.97M
PE:-2.29
High:0.4232
Open:0.3704
Low:0.3704
Close:0.3732
52wk High:2.37
52wk Low:0.2000
Shares:159.13M
Float Shares:125.00M
Volume Ratio:1.44
T/O Rate:2.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1753
EPS(LYR):-0.2627
ROE:-67.85%
ROA:-42.46%
PB:2.23
PE(LYR):-1.53

Loading ...

Sep 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
May 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 23, 2024

Major Issues Report

Form 8-K - Current report
May 21, 2024

Correspondence

Form CORRESP - Correspondence
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2024

Major Issues Report

Form 8-K - Current report
Apr 16, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Mar 27, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]